These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2167955)

  • 1. Modification of cisplatin toxicity with diethyldithiocarbamate.
    Berry JM; Jacobs C; Sikic B; Halsey J; Borch RF
    J Clin Oncol; 1990 Sep; 8(9):1585-90. PubMed ID: 2167955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicities.
    Gandara DR; Nahhas WA; Adelson MD; Lichtman SM; Podczaski ES; Yanovich S; Homesley HD; Braly P; Ritch PS; Weisberg SR
    J Clin Oncol; 1995 Feb; 13(2):490-6. PubMed ID: 7844610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Paredes J; Hong WK; Felder TB; Dimery IW; Choksi AJ; Newman RA; Castellanos AM; Robbins KT; McCarthy K; Atkinson N
    J Clin Oncol; 1988 Jun; 6(6):955-62. PubMed ID: 2836565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced therapeutic efficacy of cisplatin by combination with diethyldithiocarbamate and hyperthermia in a mouse model.
    Murthy MS; Rao LN; Khandekar JD; Scanlon EF
    Cancer Res; 1987 Feb; 47(3):774-9. PubMed ID: 3026616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study.
    Frasci G; Comella P; Scoppa G; Guida C; Gravina A; Fiore F; Casaretti R; Daponte A; Parziale A; Comella G
    J Clin Oncol; 1997 Apr; 15(4):1409-17. PubMed ID: 9193333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD; Greco FA
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weekly paclitaxel/cisplatin with concurrent radiotherapy in patients with locally advanced non-small cell lung cancer: a phase I study.
    Comella G; Frasci G; Scoppa G; Guida C; Gravina A; Fiore F; Casaretti R; Daponte A; Ruffolo P; Comella P
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-113-S12-116. PubMed ID: 9331134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose cisplatin and vinblastine infusion with or without radiation therapy in patients with advanced non-small-cell lung cancer.
    Blumenreich MS; Woodcock TM; Gentile PS; Barnes GR; Jose B; Sherrill EJ; Richman SP; Epremian BE; Kubota TT; Allegra JC
    J Clin Oncol; 1987 Nov; 5(11):1725-30. PubMed ID: 2824706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose cisplatin with diethyldithiocarbamate (DDTC) rescue therapy: preliminary pharmacologic observations.
    DeGregorio MW; Gandara DR; Holleran WM; Perez EA; King CC; Wold HG; Montine TJ; Borch RF
    Cancer Chemother Pharmacol; 1989; 23(5):276-8. PubMed ID: 2539912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trial.
    Tannehill SP; Mehta MP; Larson M; Storer B; Pellet J; Kinsella TJ; Schiller JH
    J Clin Oncol; 1997 Aug; 15(8):2850-7. PubMed ID: 9256128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel by 96-hour continuous infusion in combination with cisplatin: a phase I trial in patients with advanced lung cancer.
    Georgiadis MS; Schuler BS; Brown JE; Kieffer LV; Steinberg SM; Wilson WH; Takimoto CH; Kelley MJ; Johnson BE
    J Clin Oncol; 1997 Feb; 15(2):735-43. PubMed ID: 9053499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel in combination chemotherapy with radiotherapy in patients with unresectable stage III non-small-cell lung cancer.
    Greco FA; Stroup SL; Gray JR; Hainsworth JD
    J Clin Oncol; 1996 May; 14(5):1642-8. PubMed ID: 8622083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer.
    Millward MJ; Zalcberg J; Bishop JF; Webster LK; Zimet A; Rischin D; Toner GC; Laird J; Cosolo W; Urch M; Bruno R; Loret C; James R; Blanc C
    J Clin Oncol; 1997 Feb; 15(2):750-8. PubMed ID: 9053501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
    Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of cisplatin-induced toxicity by selected dithiocarbamates.
    Walker EM; Fazekas-May MA; Heard KW; Yee S; Montague D; Jones MM
    Ann Clin Lab Sci; 1994; 24(2):121-33. PubMed ID: 8203821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
    Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I/II trial of biweekly docetaxel and cisplatin with concurrent thoracic radiation for stage III non-small-cell lung cancer.
    Iwasaki Y; Ohsugi S; Natsuhara A; Tsubokura T; Harada H; Ueda M; Arimoto T; Hara H; Yamada T; Takesako T; Kohno K; Hosogi S; Nakanishi M; Marunaka Y; Nishimura T
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):735-41. PubMed ID: 16565832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent paclitaxel/cisplatin with thoracic radiation in patients with stage IIIA/B non-small cell carcinoma of the lung.
    Antonia SJ; Wagner H; Williams C; Alberts M; Hubbell D; Robinson L; Hilstro J; Ruckdeschel JC
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):34-7. PubMed ID: 7644926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I clinical and pharmacokinetic study of diethyldithiocarbamate as a chemoprotector from toxic effects of cisplatin.
    Qazi R; Chang AY; Borch RF; Montine T; Dedon P; Loughner J; Bennett JM
    J Natl Cancer Inst; 1988 Nov; 80(18):1486-8. PubMed ID: 2846857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.